23andMe(TM) Launches Web-Based Personal Genome Service(TM) Outside U.S., Empowering Individuals to Access and Understand Their Own Genetic Information

23andMe, Inc., a privately-held personal genetics company,
announced today that it has begun making its services available to
consumers in Canada and 49 European countries. The company, which
officially launched in the U.S. on November 16, 2007, helps
individuals understand their own genetic information through the
latest advances in DNA analysis technologies and web-based interactive
tools.

23andMe was recently selected as a 2008 Technology Pioneer by the
World Economic Forum and will be participating in the 2008 World
Economic Forum Annual Meeting from January 23-28, 2008 in Davos,
Switzerland. Representatives from the company will be available to
press and forum attendees at the 23andMe Booth on Wednesday, January
23rd to Saturday, January 26th 2008 from 10.00am - 2.00pm and 5.00pm -
11.00pm CET daily. The 23andMe Booth will be located on the first
floor of the Belvedere Hotel (Promenade 89/7270 Davos-Platz) in Davos.

The 23andMe(TM) service enables its customers to:

-- Search and explore genes contributing to their personal
characteristics, such as lactose intolerance, athletic
ability, and food preferences;

-- Learn how the latest research studies relate to their genomes;

-- Compare their profiles to family and friends who are also
23andMe participants and trace the inheritance of genes
associated with specific traits;

-- Discover genetic roots and find out where and how their
ancestors lived and learn about the prehistoric events they
experienced, and;

-- Actively participate in a new research approach and contribute
to the advancement of the field of genetics.

Linda Avey, co-founder of 23andMe, said, "We are receiving
overwhelming interest in our services outside the U.S. and are pleased
to now offer them in Canada and Europe. Our web-based service model
has made the European and Canadian offering possible, and we hope to
continue to expand our global footprint to additional locations in the
future. Ms. Avey continued, "We believe 2008 will be a year in which
our understanding of the human genome will increase significantly
through international research efforts, and we are eager to continue
connecting individuals to this growing knowledge base of genetic
information."

"23andMe came together because we believe in empowering
individuals by helping them understand their genetic make-up and
actively engaging them in the development of new ways to accelerate
research," said Anne Wojcicki, co-founder of 23andMe. "We enter the
European and Canadian markets with great momentum and are excited to
continue toward our goal of offering our services to the global
community."

How 23andMe´s services work:

-- 23andMe sends individuals a saliva kit containing a bar-coded
tube for saliva collection. Customers then use the enclosed
mailing materials to send their samples to 23andMe´s
contracted laboratory. The DNA is then extracted and exposed
to a microchip-like device made by Illumina, Inc., a leading
developer of genetic analysis tools (Nasdaq: ILMN), that reads
more than half a million points in the individual´s genome,
including a proprietary set of over 30,000 information-rich
markers, chosen by 23andMe scientists, to produce a detailed
genetic profile.

-- Once the analysis has been completed, individuals are able to
use their own private login to access their data via 23andMe´s
secure website. Using 23andMe´s web-based tools, individuals
can explore their ancestry, see what genetic research means
for them and compare themselves to friends and family members.

-- Participants become part of a community that works together to
advance the overall understanding of the human genome.

Joining the 23andMe Community

To learn more and embark on your own personal genetic journey,
please visit: www.23andMe.com.

23andMe is now available to consumers in the following locations:
Albania, Andorra, Armenia, Austria, Azerbaijan, Belarus, Belgium,
Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Cyprus, Czech
Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece,
Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Lithuania,
Luxembourg, Macedonia, Malta, Moldova, Monaco, Montenegro,
Netherlands, Norway, Poland, Portugal, Romania, Russia, San Marino,
Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey,
Ukraine, the United Kingdom, the United States and Vatican City State.

About 23andMe

23andMe, Inc. is a privately-held personal genetics company
dedicated to helping individuals understand their own genetic
information through DNA analysis technologies and web-based
interactive tools. The company´s Personal Genome Service enables
individuals to gain deeper insights into their ancestry and inherited
traits. 23andMe, Inc., was founded by Linda Avey and Anne Wojcicki in
2006, and the company is advised by a group of renowned experts in the
fields of human genetics, bioinformatics and computer science. Its
Series A investors include Genentech, Inc., Google Inc. (NASDAQ: GOOG)
and New Enterprise Associates. More information is available at
www.23andMe.com.

23andMe and Personal Genome Service are trademarks of 23andMe,
Inc. All other marks belong to their respective owners.